Expression of the CD117 antigen (C-Kit) on normal and myelomatous plasma cells

British Journal of Haematology

Volumn 95, Issue 3, 1996, Pages 489-493

  Ocqueteau, M ^a   Orfao, A ^b   Garcia Sanz R ^a   Almeida, J ^a   Gonzalez, M ^a   San Miguel, J F ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

c Kit; CD117; Multiple myeloma; Plasma cells

Indexed keywords

MEMBRANE ANTIGEN; ONCOPROTEIN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; ONCOGENE C KIT; PLASMA CELL; PRIORITY JOURNAL;

EID: 0029860302     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1996.tb08993.x     Document Type: Article

References (12)

1. Ashman, L.K., Cambareri, A.C., To, L.B., Levinsky, R.J. & Juttner, C.A. (1991) Expression of the YB5.B8 antigen (c-kit protooncogene product) in normal human bone marrow. Blood, 78, 30-37.
2. Barlogie, B., Epstein, J., Selvanayagam, P. & Alexanian, R. (1989) Plasma cell myeloma: new biological insights and advances in therapy. Blood, 73, 865-879.
3. Bühring, H., Ashman, L., Gattei, V., Kniep, B., Larregina, A., Pinto, A., Valent, P. & van den Oord, J. (1995) Stem cell factor receptor (p145 (c-kit)) summary report (CD117). Leukocyte Typing V. White Cell Differentiation Antigens, Vol. 2 (ed. by S. F. Schlossman), pp. 1882-1883. Oxford University Press.
4. Chronic Leukemia Myeloma Task Force. National Cancer Institute (1973) Proposed guidelines for procolol studies. II. Plasma cell myeloma. Cancer Chemotherapy Reports, 4, 145-158.
5. Durie, B.G.M. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer, 36, 842-854.
6. Jackson, N., Ling, N.R., Ball, J., Bromidge, E., Nathan, P.D. & Franklin, I.M. (1988) An analysis of myeloma plasma cells phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens. Clinical and Experimental Immunology, 72, 351-356.
7. Lemoli, R.M., Fortuna, A., Grande, A., Gamberi, B., Bonsi, L., Fogli, M. Amabile, M., Cavo, M., Ferrari, S. & Tura, S. (1994) Expression and functional role of c-kit ligand (SCF) in human multiple myeloma cells. British Journal of Haematology, 88, 760-769.
8. Noruris, M.G. (1990) SPSS® Base System User's Guide. SPSS® 4.0 for the Macintosh. SPSS Inc., Chicago.
9. Orfão, A., García-Sanz, R., López-Berges, M.C., Vidriales, M.B., González, M., Caballero, M.D. & San Miguel, J.F. (1994) A new method for the analysis of plasma cell DNA content in multiple myeloma samples using a CD38/propidium iodide double staining technique. Cytometry, 17, 332-339.
10. Papayannoupoulou, T., Brice, M., Broudy, V.C. & Zsebo, K.M. (1991) Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood and fetal liver: functional properties and composite antigenic profile. Blood, 78, 1403-1412.
11. San Miguel, J.F., García-Sanz, R., González, M. & Orfão, A. (1995) Immunophenotype and DNA content in multiple myeloma. Bailliere's Clinical Haematology, 8, 735-759.
12. Sekido, I., Obata, Y., Ueda, R., Hida, T., Suyama, M., Shimokata, K., Ariyoshi, Y. & Takahashi, T. (1991) Preferential expression of c-kit protooncogene transcripts in a small cell lung cancer. Cancer Research, 51, 2416-2419.